The Objectives of the Cartilage Repair Registry is to Report Long Term Efficacy and Safety of Cartilage Repair Procedures in Registry Patients
Information source: Vericel Corporation
ClinicalTrials.gov processed this data on August 20, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Articular Cartilage; Cartilage Diseases
Intervention: Carticel (autologous cultured chondrocyte) implantation (Biological)
Phase: Phase 4
Status: Completed
Sponsored by: Vericel Corporation Official(s) and/or principal investigator(s): Medical Monitor, Study Director, Affiliation: Genzyme, a Sanofi Company
Summary
The objectives of the Cartilage Repair Registry is to report the long term efficacy and
safety of cartilage repair procedures in Registry patients.
Clinical Details
Official title: Cartilage Repair Registry
Study design: Observational Model: Case-Only
Primary outcome: Physician assessment of effectiveness of autologous chondrocyte implantationPhysician assessment of effectiveness of autologous chondrocyte implantation Physician assessment of effectiveness of autologous chondrocyte implantation
Secondary outcome: Patient assessment of effectiveness of autologous chondrocyte implantation
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- All registry patients meeting the cohort definition at the pre-operative visit will
be included on the overall summary tables for the patient cohort
Exclusion Criteria:
- All registry patients meeting the cohort definition at the pre-operative visit will
be included on the overall summary tables for the patient cohort
Locations and Contacts
Registry contains data from patients whom were implanted by 1123 surgeons in the U.S. and also data captured on patients treated by 154 surgeons in 15 other countries., Cambridge, Massachusetts 02142, United States
Additional Information
Starting date: March 1995
Last updated: August 17, 2015
|